Anti-rods/rings autoantibody seropositivity does not affect response to telaprevir treatment for chronic hepatitis C infection

ConclusionsOverall, the data suggest that anti-RR seropositivity is not associated with resistance to TPV treatment in this patient cohort, but monitoring anti-RR-positive patients for relapse within the first 6 months after treatment may be useful.

http://link.springer.com/10.1007/s13317-016-0087-9

Source: Autoimmunity Highlights - November 13, 2016 Category: Allergy & Immunology Source Type: research